Pharma Data Mining Restriction Options Available
The PDRP "enables physicians to ‘opt out’ of such disclosure quickly and easily, while still allowing their data to be available for academic and governmental research," the AMA statement said.
“We believe the PDRP balances individual physician concerns regarding prescription data with First Amendment freedoms and the fundamental public interest in robust medical research."
Mello and Messing said the Supreme Court decision "may offer an unexpected dividend to opponents of data mining: The surrounding publicity might alert physicians to their right to opt out of sharing their prescribing information through the PDRP."
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- Two-Midnight Rule Must be Fixed or Replaced, Say Providers
- Don't Underestimate Emotional Intelligence
- The Secret to Physician Engagement? It's Not Better Pay
- Care Coordination Tough to Define, Measure
- Yale New Haven Health Partners with Tenet Healthcare in CT
- Size Matters in Antibiotic Overuse
- Physicians Take SGR Repeal Message to Washington
- CDC Warns of Antibiotic Overuse in Hospitals
- 4 Reasons PCMH Principles Aren't Going Away
- SCOTUS Review of NC Board Case 'A Very Big Deal' to Providers